Evidence map›Paper›PMID 39737345›Full record

ArticleBMJ neurology open2024

Mixed-methods process evaluation of a proactive approach to healthcare in Parkinson's disease-ParkProReakt: a protocol of a hybrid efficacy-implementation study.

Natalie Altschuck, Marlena van Munster, Johanne Stümpel, David Jose Pedrosa, Ingmar Wellach, Hannes Boebinger, Max Geraedts, ParkProReakt Collaborator Group

Abstract read
In one paragraph

Article in BMJ neurology open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Natalie AltschuckInstitute for Health Services Research and Clinical Epidemiology, Philipps University Marburg, Marburg, Germany.ORCID 0009-0007-7857-2139
Marlena van MunsterDepartment of Neurology, Philipps University Marburg, Marburg, Germany.
Johanne StümpelDepartment of Neurology, Philipps University Marburg, Marburg, Germany.ORCID 0000-0002-3690-1295
David Jose PedrosaDepartment of Neurology, University Hospital of Giessen and Marburg Campus Marburg, Marburg, Germany.
Ingmar WellachPraxis für Neurologie und Psychiatrie Hamburg Walddörfer, Hamburg, Germany.
Hannes BoebingerInnovationsfonds & Produktportfolio, Techniker Krankenkasse, Hamburg, Germany.
Max GeraedtsInstitute for Health Services Research and Clinical Epidemiology, Philipps University Marburg, Marburg, Germany.
ParkProReakt Collaborator Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractIntroduction: People with Parkinson's disease (PwPD) experience a wide range of motor and non-motor symptoms that have a significant impact on their health and quality of life. Effective care management for PwPD involves monitoring symptoms at home, involving specialised multidisciplinary care providers and enhancing self-management skills. This study protocol describes the process evaluation within a randomised clinical trial to assess the implementation and its impact on patient health outcomes of ParkProReakt-a proactive, multidisciplinary, digitally supported care model for community-dwelling PwPD. Methods and analysis: The hybrid efficacy-implementation study will assess key implementation outcomes using the Medical Research Council framework for complex interventions alongside a randomised controlled trial. A combination of quantitative and qualitative methods will be used to assess process data from care providers and patients. The main process outcomes are fidelity, dose, feasibility and context. Context will be analysed through semistructured interviews and focus groups using the Consolidated Framework of Implementation Research. To elucidate potential facilitators and barriers to implementation and to gain deeper insights into the efficacy outcome data, quantitative and qualitative process data will be integrated at an interpretative level using mixed methods. In addition to process evaluation, potential indirect mechanisms of impact will be measured. Ethics and dissemination: Ethical approval for this study was obtained from the responsible state medical ethics committees in Hesse and Hamburg, Germany. Results will be communicated to the funding body and disseminated through scientific publications. Trial registration: This study was registered with the German Registry for Clinical Studies (DRKS)-number: DRKS00031092.

Indexed as

PARKINSON'S DISEASEQUALITY OF LIFE

Identifiers

PMID39737345
PMCPMC11683930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.